Weight Loss Medicines
Rybelsus 14 Mg Tablet
₹ 3450 / Stripe Get Latest Price
strength 14 mg
Form Tablets
Packaging size 10*10 Tablets
Packaging Type Strip
Composition Semaglutide
Brand Rybelsus 14 Mg
Prescription/Non prescription Prescription
Shelf Life 24 Months
Usuage to treat type 2 diabetes
Prescription / Non Prescription Prescription
RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.
It is not known if RYBELSUS® can be used in people who have had pancreatitis
RYBELSUS® is not for use in people with type 1 diabetes
It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age
Key takeaways:
Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management.
Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes.
Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name.
Send Message